MedPath

Mitralign, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)

Not Applicable
Conditions
Chronic Symptomatic Functional Tricuspid Regurgitation
Tricuspid Valve Insufficiency
Heart Valve Disease
Interventions
Device: Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
First Posted Date
2017-07-21
Last Posted Date
2018-02-07
Lead Sponsor
Mitralign, Inc.
Target Recruit Count
60
Registration Number
NCT03225612
Locations
🇩🇪

CardioVascular Center Frankfurt, Frankfurt, Germany

🇩🇪

Herzzentrum Leipzig - Universitätsklinik, Leipzig, Germany

🇩🇪

German Heart Center Munich, Munich, Germany

and more 8 locations

Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlignâ„¢.

Not Applicable
Conditions
Heart Valve Disease
Tricuspid Valve Insufficiency
Chronic Symptomatic Functional Tricuspid Regurgitation
Interventions
Device: Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
First Posted Date
2015-10-14
Last Posted Date
2017-10-27
Lead Sponsor
Mitralign, Inc.
Target Recruit Count
30
Registration Number
NCT02574650
Locations
🇺🇸

Piedmont Healthcare, Atlanta, Georgia, United States

🇺🇸

Houston Methodist, Houston, Texas, United States

🇺🇸

University of Virginia, Charlottesville, Virginia, United States

and more 8 locations

Mitralign Percutaneous Annuloplasty First in Man Study

Not Applicable
Completed
Conditions
Functional Mitral Regurgitation
Interventions
Device: MPAS Implant
First Posted Date
2013-05-13
Last Posted Date
2016-03-18
Lead Sponsor
Mitralign, Inc.
Target Recruit Count
35
Registration Number
NCT01852149
Locations
🇧🇷

Instituto Dante Passanese de Cardiologia, Sao Paulo, Brazil

🇩🇪

Universitats Klinikum Bonn, Bonn, Germany

🇩🇪

Asklepios Klinik St Georg, Hamburg, Germany

and more 2 locations

Mitralign Percutaneous Annuloplasty System for Chronic Functional Mitral Valve Regurgitation

Not Applicable
Conditions
Mitral Valve Regurgitation
Interventions
Device: percutaneous annuloplasty
First Posted Date
2012-12-04
Last Posted Date
2016-10-17
Lead Sponsor
Mitralign, Inc.
Target Recruit Count
50
Registration Number
NCT01740583
Locations
🇫🇷

Bordeaux Heart University Hospital, Bordeaux-Pessac, France

🇨🇴

Antonio Dager, MD, Valle del Cauca, Cali, Colombia

🇵🇱

Instytutem Kardiologii, Warsaw, Poland

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath